Full-Time

ML Ops Engineer

Posted on 10/31/2025

Deadline 1/1/26
Evolent

Evolent

1,001-5,000 employees

Delivers value-based care through analytics

No salary listed

Pune, Maharashtra, India

Remote

Must have 50 Mbps broadband and wired home connection for remote work.

US Citizenship, US Top Secret Clearance, Canada Citizenship, Canada Top Secret Clearance, UK Citizenship, UK Top Secret Clearance Required

Category
Operations & Logistics (1)
Requirements
  • Bachelor’s Degree in Computer Science, Machine Learning, Data Science, or a related field
  • 4+ years of experience in MLOps, DevOps, or ML engineering
  • Proficiency in Python and ML frameworks such as Keras, PyTorch, Scikit-Learn, TensorFlow, and XGBoost
  • Experience with containerization (Docker), orchestration (Kubernetes), and CI/CD tools
  • Familiarity with healthcare datasets and privacy regulations
  • Strong analytical skills to interpret model performance data and identify optimization opportunities
  • Proven ability to optimize application performance, including improving code efficiency, right-sizing infrastructure usage, and reducing system latency
  • Experience implementing rollback strategies, including version control, rollback triggers, and safe deployment practices across lower and upper environments
  • 3+ years of experience developing in a cloud environment (AWS, GCS, Azure)
  • 3+ years of experience with Github, Github Actions, CI/CD, and source control
  • 3+ years working within an Agile environment
Responsibilities
  • Design, build, and maintain scalable, secure ML pipelines for model training, validation, deployment, and monitoring
  • Automate deployment workflows using CI/CD pipelines and infrastructure-as-code tools
  • Partner with Infrastructure Teams to manage (Azure) cloud-based ML infrastructure, ensuring compliance with InfoSec and AI policies
  • Ensure applications run at peak efficiency
  • Develop rigorous testing frameworks for ML models, including clinical validation, traditional model performance measures, population segmentation, and edge-case analysis
  • Build monitoring systems to detect model drift, overfitting, data anomalies, and performance degradation in real-time
  • Continuously analyze model performance metrics and operational logs to identify improvement opportunities
  • Translate monitoring insights into actionable recommendations for data scientists to improve model precision, recall, fairness, and efficiency
  • Maintain detailed audit trails, logs, and metadata for all model versions, training datasets, and configurations to ensure full traceability and support internal audits
  • Ensure models meet transparency and explainability standards using tools like SHAP, LIME, or integrated explainability APIs.
  • Collaborate with data scientists and clinical teams to ensure models are interpretable, actionable, and aligned with practical applications
  • Support corporate Compliance and AI Governance policies
  • Advocate for best practices in ML engineering, including reproducibility, version control, and ethical AI
  • Develop product guides, model documentation, and model cards for internal and external stakeholders
Desired Qualifications
  • Experience with MLOps platforms like MLflow, TFX, or Kubeflow
  • Healthcare experience, particularly using administrative and prior authorization data
  • Proven experience with developing and deploying ML systems into production environments
  • Experience working with Product, Engineering, Infrastructure, and Architecture teams
  • Proficiency using Azure cloud-based services and infrastructure such as Azure MLOps
  • Experience with feature flagging tools and strategies
  • None

Evolent Health helps healthcare organizations transition to value-based care by pairing technology, analytics, and clinical expertise to improve patient outcomes while lowering costs. It partners with health systems, physician groups, and health plans to deliver data-driven care coordination, population health management, and risk-adjustment services. The company’s offerings include software platforms, analytics, and clinical support that enable more efficient care delivery, shared savings programs, and performance-based incentives. Compared with competitors, Evolent emphasizes end-to-end collaboration with clients and a diversified client base, combining technology with hands-on clinical and operational expertise to drive measurable outcomes. Its goal is to help clients succeed in value-based models by delivering better patient care at lower total costs.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Arlington, Virginia

Founded

2011

Simplify Jobs

Simplify's Take

What believers are saying

  • Oncology launches with Highmark and Aetna drive $2.4-2.6B 2026 revenue guidance.
  • Performance Suite expansion generates over $200M annual revenue from new agreements.
  • Archie Mayani's 2026 appointment accelerates AI in prior authorizations and clinical support.

What critics are saying

  • 7x leverage and $398M Q4 2025 goodwill impairment trigger covenant breaches by mid-2027.
  • Q1 2026 6.9% revenue miss erodes confidence, limits capital access post-$145M notes.
  • Privia Health's 17.4% Q4 growth captures share as Evolent posts flat $468.7M revenue.

What makes Evolent unique

  • Evolent unifies oncology, cardiology, musculoskeletal solutions under single platform post-2023 rebrand.
  • Serves 41 million enrollees with clinician-led pathways and technology-enabled decision support.
  • Focuses exclusively on value-based specialty care after divesting primary care to Privia in 2025.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Flexible Work Hours

Hybrid Work Options

Performance Bonus

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

1%

2 year growth

0%
Yahoo Finance
Mar 19th, 2026
Evolent appoints Archie Mayani as chief product officer to drive AI innovation in healthcare

Evolent Health has appointed Archie Mayani as chief product officer. Mayani brings over 20 years of experience in healthcare technology and AI innovation from roles at GHX, Change Healthcare, UnitedHealth Group and Amazon. Most recently, Mayani served as CPO at GHX, where she developed AI-powered capabilities for healthcare supply chains. At Change Healthcare, she led clinical decision support and revenue cycle platforms, focusing on reducing administrative burden in prior authorisation. During her time at Optum and UnitedHealth Group, she scaled value-based care programmes that improved Medicare STARS performance and reduced hospital utilisation. Mayani also served as global head of product and content operations for Amazon Prime Video. She has received multiple industry honours, including the Global CPO Award in 2025 and Inspiring Leader Award in 2023.

Yahoo Finance
Mar 7th, 2026
Evolent Health drops to $5.18 fair value on 7x leverage and $398M goodwill impairment

Evolent Health faces a shifting investment narrative after analysts reset expectations, with fair value estimates dropping from $8.50 to $5.18. The revision reflects concerns about reserves, leverage and margin visibility. Despite lowered price targets, Oppenheimer, BTIG, UBS, Citi, Truist and Canaccord maintain positive ratings, citing conservative reserving and new contracts as potential margin support. Analysts view new CFO Mario Ramos as bringing increased transparency. However, KeyBanc downgraded to Sector Weight, highlighting leverage at approximately 7x and limited EBITDA recovery visibility. Multiple firms reduced 2026-2028 earnings assumptions amid medical cost pressures and ACA exchange membership concerns. Evolent recorded a $398 million goodwill impairment for Q4 2025 and issued 2026 revenue guidance of $2.4 billion to $2.6 billion.

Yahoo Finance
Feb 25th, 2026
Evolent Health shares jump 20.7% on Q4 beat and strong 2026 revenue guidance

Evolent Health shares surged 20.7% after the healthcare solutions company reported fourth-quarter earnings that beat expectations and issued optimistic revenue guidance. The company posted non-GAAP earnings of $0.08 per share, significantly improved from a $0.02 per share loss a year earlier and ahead of analyst forecasts. Whilst quarterly revenue fell 27.5% year-on-year to $468.7 million, meeting expectations, investors focused on strong future guidance. Evolent projected full-year 2026 revenue between $2.4 billion and $2.6 billion, with the midpoint suggesting approximately 30% growth and nearly 5% above analyst estimates. The shares are trading at $3.15, down 19.2% year-to-date and 73.3% below their 52-week high of $11.79 from July 2025.

Pulse Nigeria
Sep 24th, 2025
Privia Health Acquires Evolent's ACO Business To Boost Value-Based Care

Privia Health acquires Evolent's ACO business to boost value-based care.

Healthcare Dive
Sep 24th, 2025
Privia acquires Evolent's value-based primary care unit for $100M

Privia Health is acquiring a value-based primary care business from Evolent Health as the physician enablement company continues to expand its care delivery network into new geographies.

INACTIVE